We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Upper GI Focus Group

The ESTRO Upper Gastrointestinal Focus Group is a team of experts dedicated to supporting the activities of ESTRO Councils and Committees in upper GI oncology.

The Focus Group serves as a platform for interaction, facilitating the exchange of existing knowledge and the development of future activities related to oesophageal, gastric, liver, and pancreatic tumours. Its role includes assisting in the development of technical and clinical guidelines, planning and executing educational events, distributing and analysing surveys, and supporting the dissemination of scientific content. ESTRO Councils and Committees can also seek input and assistance from the Upper GI Focus Group.

Given the highly interdisciplinary nature of upper GI oncology, the Upper GI Focus Group aims to harmonise current and future scientific and educational projects, both within ESTRO and by actively engaging with other professional societies, such as the European Society for Medical Oncology (ESMO), the European Society of Surgical Oncology (ESSO), the European Association for the Study of the Liver (EASL), United European Gastroenterologists (UEG), and the European Organisation for Research and Treatment of Cancer (EORTC).

The Upper GI Focus Group welcomes the interest and suggestions of all ESTRO members, with the ultimate goal of advancing patient care through the rigorous application of evidence-based medicine and the continuous education of radiation oncologists, medical physicists, and radiation therapists (RTTs).

The Focus Group's initiatives and projects aim to comprehensively incorporate and report on all areas of neuro-oncology and radiation oncology. These are not limited to but include preclinical and clinical research, critical and systematic reviews, imaging modalities, planning and target delineation, irradiation techniques and reirradiation, the use of artificial intelligence, quality of life, cancer survivorship, assessment and use of biomarkers, education of involved professions, dissemination of relevant research and guidelines, and the assessment of current and future challenges in the field.

The Focus Group composition should facilitate collaboration within and outside Europe, and should also secure synergy, collaboration and alignment within ESTRO:

  • Within ESTRO: SBRT Focus Group, Systemic Therapy Focus Group, GEC-ESTRO Committee and other ESTRO committees
     
  • ​Other societies: ESMO, ESSO, EASL, UEG, EORTC, IASGO, ASTRO, AAPM, IAEA etc.

Chair:

Thomas Brunner, Radiation Oncologist, University Hospital for Radiation Therapy Graz, (AT)

Core Experts:

Karin Haustermans, Radiation Oncologist, University Hospital Leuven and KU Leuven  (BE)

Maria Hawkins, Radiation Oncologist, University College London (UK)

Full Members:

Florence Huguet, Radiation Oncologist, Assistance Publique - Hôpitaux de Paris, Sorbonne Université Paris (FR)

Gilles Créhange, Radiation Oncologist, Institut Curie (FR)

Eleni Gkika, Radiation Oncologist, University Medical Center Bonn  (DE)

Rainer Fietkau, Radiation Oncologist, University Hospital Erlangen (DE)

Francesco Cellini, Radiation Oncologist, Fondazione Policlinico Universitario A. Gemelli IRCCS Rome (IT)

Alessio G. Morganti, Radiation Oncologist, University of Bologna (IT)

Marcel Verheij, Radiation Oncologist, Radboud University Medical Center  (NL)

Peter van Rossum, Radiation Oncologist, Amsterdam UMC (NL)

Eva Versteijne, Radiation Oncologist, Amsterdam UMC (NL)

Felipe A. Calvo, Radiation Oncologist, Clínica Universidad de Navarra (ES)

Gert Meijer, Medical Physicist, Utrecht UMC (NL)

Mairead Daly, RTT, University of Manchester (UK)

Tiuri E. Kroese, Radiation Oncologist in training, University of Zurich (CH)

Pieter Populaire, Radiation Oncologist, University Hospitals Leuven (BE)

More information coming soon.